FDA+ channel feed – Endpoints News

FDA+ channel feed

Exclusive: After FDA firings, drug reviewers are asked to volunteer for administrative work

Last month

White House budget request would cut billions at NIH and CDC, add $500M for MAHA

Last month

FDA withdraws two final guidances, pulls compliance deadlines for bone allograft makers

Last month

Missing REMS delays Cytokinetics' heart drug PDUFA, stock drops

Last month

FDA adcomms slated to review data on long-term opioid use, overdoses

Last month

RFK Jr. claims placebo-controlled vaccine trials are 'radical departure' from past. Experts disagree

Last month

FDA approves Satsuma's migraine nasal spray after rejection in 2024

Last month

Exits continue at FDA, as more staff in drug office follow fired colleagues out the door

Last month

FDA approves J&J's rare disease drug that's expected to compete with argenx and UCB

Last month

FDA approves Abeona’s skin disease cell therapy

Last month

FDA won't reorganize medical product centers, Makary says in interview: 'I rejected that proposal'

Last month

FDA delays PDUFA date for small biotech, raising questions about impact of agency cuts

Last month

Vaxart says it can resume next-gen Covid work, will screen participants for oral vaccine trial

Last month

Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny

Last month

European regulators recommend new drugs from Vertex, Amgen and Jazz

Last month

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

Last month

Only two-thirds of FDA-approved biosimilars have launched, report finds

Last month

Cassidy urges congressional reforms to 340B drug discount program after investigation

Last month

Large vaccine makers stand by their investments despite US headwinds

Last month

Top pharma companies increased lobbying spend in first quarter of 2025

Last month

FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approval

Last month

Recent FDA staff cuts to delay drug hearing decision by months, agency tells Vanda

Last month

FDA plans to ban pharma employees from serving on adcomms. The impact will be limited

Last month

Makary, in one of first comments on FDA policy, floats new pathway for rare disease drugs

Last month

First page Previous page 1 2 345 6 7 Next page Last page